To me as a layman, this seems “simple” enough to have been found in the previous few decades of research. Why is it coming up only now?
The investment probably doesn’t scale linearly but I imagine there’s a compounding effect.
They’re just waiting to die in their 60s ~ 80s from exactly the thing they could cure in their 50s.
The US economy is $23 trillion a year. It makes no sense that we don’t double medical research tomorrow. We’re either going to have a similar fate, or will personally know someone who will.
But administrative bloat, salaries of upper-end administrators, etc. can be scaled up extremely fast.